Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer
NCT00046540
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms
Interventions
DRUG:
Liposome-encapsulated SN38
Sponsor
INSYS Therapeutics Inc